Article thumbnail

Magnesium Limitation Is an Environmental Trigger of the Pseudomonas aeruginosa Biofilm Lifestyle

By Heidi Mulcahy and Shawn Lewenza


Biofilm formation is a conserved strategy for long-term bacterial survival in nature and during infections. Biofilms are multicellular aggregates of cells enmeshed in an extracellular matrix. The RetS, GacS and LadS sensors control the switch from a planktonic to a biofilm mode of growth in Pseudomonas aeruginosa. Here we detail our approach to identify environmental triggers of biofilm formation by investigating environmental conditions that repress expression of the biofilm repressor RetS. Mg2+ limitation repressed the expression of retS leading to increased aggregation, exopolysaccharide (EPS) production and biofilm formation. Repression of retS expression under Mg2+ limitation corresponded with induced expression of the GacA-controlled small regulatory RNAs rsmZ and rsmY and the EPS biosynthesis operons pel and psl. We recently demonstrated that extracellular DNA sequesters Mg2+ cations and activates the cation-sensing PhoPQ two-component system, which leads to increased antimicrobial peptide resistance in biofilms. Here we show that exogenous DNA and EDTA, through their ability to chelate Mg2+, promoted biofilm formation. The repression of retS in low Mg2+ was directly controlled by PhoPQ. PhoP also directly controlled expression of rsmZ but not rsmY suggesting that PhoPQ controls the equilibrium of the small regulatory RNAs and thus fine-tunes the expression of genes in the RetS pathway. In summary, Mg2+ limitation is a biologically relevant environmental condition and the first bonafide environmental signal identified that results in transcriptional repression of retS and promotes P. aeruginosa biofilm formation

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2009). A novel signaling network essential for regulating Pseudomonas aeruginosa biofilm development.
  2. (2004). A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa.
  3. (2005). A three-component regulatory system regulates biofilm maturation and type III secretion in Pseudomonas aeruginosa.
  4. (2005). An expression vector containing a rhamnoseinducible promoter provides tightly regulated gene expression in Burkholderia cenocepacia.
  5. (2006). Analysis of Pseudomonas aeruginosa conditional psl variants reveals roles for the psl polysaccharide in adhesion and maintaining biofilm structure postattachment.
  6. (2003). Application of comparative genomics in the identification and analysis of novel families of membrane-associated receptors in bacteria.
  7. (1999). Bacterial biofilms: A common cause of persistent infections.
  8. (1994). Bacterial gene transfer by natural genetic transformation in the environment.
  9. (2006). Basis for N-acetyllactosamine-mediated inhibition of enteropathogenic Escherichia coli localized adherence.
  10. (2005). Biofilms: The matrix revisited.
  11. (2003). Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa.
  12. (2003). Cell death in Pseudomonas aeruginosa biofilm development.
  13. (2006). Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm.
  14. (1998). Cluster analysis and display of genome-wide expression patterns.
  15. (2001). Comparison of the Pseudomonas aeruginosa and escherichia coli PhoQ sensor domains: Evidence for distinct mechanisms of signal detection.
  16. (2005). Construction of a mini-Tn5-luxCDABE mutant library in Pseudomonas aeruginosa PAO1: A tool for identifying differentially regulated genes.
  17. (2006). Contribution of the PhoP-PhoQ and PmrA-PmrB two-component regulatory systems to Mg2+-induced gene regulation in Pseudomonas aeruginosa.
  18. (2001). Cystic fibrosis pathogenesis and the role of biofilms in persistent infection.
  19. (2007). Detergent-induced cell aggregation in subpopulations of Pseudomonas aeruginosa as a preadaptive survival strategy.
  20. (2009). Determination of the regulon and identification of novel mRNA targets of Pseudomonas aeruginosa RsmA.
  21. (2008). Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections.
  22. (1995). DNA concentration and length in sputum of patients with cystic fibrosis during inhalation with recombinant human DNase.
  23. (2002). Effects of quorum-sensing deficiency on Pseudomonas aeruginosa biofilm formation and antibiotic resistance.
  24. (1993). Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis.
  25. (1996). Engineering actin-resistant human DNase I for treatment of cystic fibrosis.
  26. (2009). Evolving concepts in biofilm infections.
  27. (2005). Exopolysaccharide sugars contribute to biofilm formation by Salmonella enterica serovar typhimurium on HEp-2 cells and chicken intestinal epithelium.
  28. (1985). Exopolysaccharide-deficient mutants of rhizobium meliloti that form ineffective nodules.
  29. (2008). Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms.
  30. (2002). Extracellular DNA required for bacterial biofilm formation.
  31. (1998). Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development.
  32. (2002). Genetic analysis of Salmonella enteritidis biofilm formation: Critical role of cellulose.
  33. (1978). Host and microbial DNA in the gut lumen.
  34. (2005). Inactivation of the pst system reduces the virulence of an avian pathogenic Escherichia coli O78 strain.
  35. (1983). Infections caused by Pseudomonas aeruginosa.
  36. (2008). Innate and induced resistance mechanisms of bacterial biofilms.
  37. (1999). Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. cystic fibrosis inhaled tobramycin study group.
  38. (2001). Mechanisms of biofilm resistance to antimicrobial agents.
  39. (2003). Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication.
  40. (2006). Multiple sensors control reciprocal expression of Pseudomonas aeruginosa regulatory RNA and virulence genes.
  41. (2008). Novel inner membrane retention signals in Pseudomonas aeruginosa lipoproteins.
  42. (2005). Off the hook–how bacteria survive protozoan grazing.
  43. (1980). Outer membrane protein H1 of Pseudomonas aeruginosa: Involvement in adaptive and mutational resistance to ethylenediaminetetraacetate, polymyxin B, and gentamicin.
  44. (2010). Phenotypic and metabolic profiling of colony morphology variants evolved from Pseudomonas fluorescens biofilms. Environ Microbiol.
  45. (1999). PhoP-PhoQ homologues in Pseudomonas aeruginosa regulate expression of the outer-membrane protein OprH and polymyxin B resistance.
  46. (2004). Pseudomonas aeruginosa attachment and biofilm development in dynamic environments.
  47. (2010). Pseudomonas aeruginosa biofilm matrix polysaccharide psl is regulated transcriptionally by RpoS and post-transcriptionally by RsmA. Mol Microbiol. Magnesium Limitation Promotes Biofilm Formation PLoS
  48. (2009). Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.
  49. (2001). Pseudomonas aeruginosa GacA, a factor in multihost virulence, is also essential for biofilm formation.
  50. (2010). Pseudomonas aeruginosa produces an extracellular deoxyribonuclease that is required for utilization of DNA as a nutrient source.
  51. (1997). Pseudomonas aeruginosa: Assessment of risk from drinking water.
  52. (2000). Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms.
  53. (2009). Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa.
  54. (2010). Regulatory RNAs and the HptB/RetS signalling pathways fine-tune Pseudomonas aeruginosa pathogenesis.
  55. (2007). Release and persistence of extracellular DNA in the environment.
  56. (2007). Role of polysaccharides in Pseudomonas aeruginosa biofilm development.
  57. (2009). The GacS/GacA signal transduction system of Pseudomonas aeruginosa acts exclusively through its control over the transcription of the RsmY and RsmZ regulatory small RNAs.
  58. (2001). The global posttranscriptional regulator RsmA modulates production of virulence determinants and N-acylhomoserine lactones in Pseudomonas aeruginosa.
  59. (1998). The involvement of cell-to-cell signals in the development of a bacterial biofilm.
  60. (2001). The multicellular morphotypes of Salmonella typhimurium and Escherichia coli produce cellulose as the second component of the extracellular matrix.
  61. (2010). The novel two-component regulatory system BfiSR regulates biofilm development by controlling the small RNA rsmZ through CafA.
  62. (2008). The PhoQ histidine kinases of Salmonella and Pseudomonas spp. are structurally and functionally different: Evidence that pH and antimicrobial peptide sensing contribute to mammalian pathogenesis.
  63. (2006). Two GacAdependent small RNAs modulate the quorum-sensing response in Pseudomonas aeruginosa.
  64. (2004). Two genetic loci produce distinct carbohydraterich structural components of the Pseudomonas aeruginosa biofilm matrix.
  65. (2000). Two-component signal transduction.